Tempest Therapeutics Inc. (TPST)
NASDAQ · Healthcare
Tempest Therapeutics Inc. annual/quarterly shareholder equity history from 2013 to 2017. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Tempest Therapeutics Inc. shareholder equity for the quarter ending December 31, 2017 were -130.7M, a 220.77% decrease year-over-year.
- Tempest Therapeutics Inc. shareholder equity for 2017 were -130.7M, a 220.77% decrease from 2016.
- Tempest Therapeutics Inc. shareholder equity for 2016 were 108.2M, a 14.69% decrease from 2015.
- Tempest Therapeutics Inc. shareholder equity for 2015 were 126.8M, a 129.28% increase from 2014.
- Tempest Therapeutics Inc. shareholder equity for 2014 were 55.3M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Tempest Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2017 | $-131 |
| 2016 | $108 |
| 2015 | $127 |
| 2014 | $55 |
| 2013 | $42 |
| Tempest Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2017-12-31 | $-131 |
| 2016-12-31 | $108 |
| 2015-12-31 | $127 |
| 2014-12-31 | $55 |
| 2013-12-31 | $42 |
Tempest Therapeutics Inc. Shareholder Equity — FAQ
Tempest Therapeutics Inc. (TPST) shareholder equity over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TPST's shareholder equity history?
The chart and table above show Tempest Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.